Pfizer panicking after judge orders accelerated release of COVID vaccine documents amid fears "business will be harmed"
One of the primary COVID-19 vaccine makers, Pfizer, appears to be panicking after a federal judge has ruled the company cannot delay the release of documents sought after by media and organizations regarding the testing clinical trials used to justify the rapid distribution of the jabs.
The drugmaker supported an effort by the corrupt Food and Drug Administration to delay the release of nearly 400,000 pages of documents in an obvious effort to shield its failure to produce a legitimate, effective vaccine -- otherwise, why try to keep the data hidden?
"Federal judge Mark Pittman of the U.S. District Court for the Northern District of Texas, in an order issued Feb. 2
, said the FDA must release redacted versions of the documents in question according to the following disclosure schedule," Children's Health Defense's The Defender noted in a report
- 10,000 pages apiece, due on or before March 1 and April 1, 2022.
- 80,000 pages apiece, to be produced on or before May 2, June 1 and July 1, 2022.
- 70,000 pages to be produced on or before Aug. 1, 2022.
- 55,000 pages per month, on or before the first business day of each month thereafter, until the release of the documents has been completed.
So not only has Pittman ordered the drugmaker to release the documents, but he's not messing around: He wants them revealed quickly, over the course of a few months, not years (and certainly not over the course of 75 years, which is what the FDA and Pfizer originally sought).
"Last week’s ruling is the most recent development in an ongoing court case that began with a Freedom of Information Act (FOIA) request filed in August 2021 by Public Health and Medical Professionals for Transparency (PHMPT), a group of doctors and public health professionals," The Defender noted.
"PHMPT, a group of more than 30 medical and public health professionals and scientists from institutions such as Harvard, Yale, and UCLA, in September 2021 filed a lawsuit against the FDA
after the agency denied its original FOIA request."
In response, the FDA claimed that it did not have the staff or resources to redact and release that many documents per month, stating instead that the agency could only produce about 500 documents monthly -- meaning all of the documents would finally be released after nearly everyone alive today is dead.
Meanwhile, as reported by SHTF Plan
, Pfizer has quietly issued a warning regarding “unfavorable safety data” getting out into the public realm without being appropriately censored, which again, can only mean the company is panicking over having to be transparent about testing and clinical trial data.
This all comes after the Big Pharma company projected $54 billion in annual COVID-19 vaccine sales not long ago, the outlet noted further.
Also, as noted by Rubicon Capital’s Kelly Brown on Twitter, it appears as though Pfizer is concerned that the coronavirus is not going to be around much longer, at least in an allegedly dangerous form:
He notes a section in a recent report "...the possibility that COVID-19 will diminish in severity or prevalence, or disappear entirely," which means profits, too, of course.
Here's part of what Pfizer may be trying to hide, as Natural News reported in November
: Higher death rates among the vaccinated during clinical trials:
Pfizer-BioNTech basically trimmed off 30 percent of the deaths to make it appear as though those who took its injections fared better than those who did not. The reality is that more people died after getting “vaccinated” than died receiving a “placebo” (which was really just another type of injection).
“These were not just COVID deaths,” reported Alex Berenson about this discovery. “In fact, they were mostly not from COVID
“Only three of the people in the trial died of COVID-related illnesses – one who received the vaccine, and two who received the saline shot. The other deaths were from other illnesses and diseases, mostly cardiovascular.”
Bring on the full disclosure.